New PARP1 inhibitor IMP1734 enters human trials for advanced cancers
NCT ID NCT06253130
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new drug called IMP1734 in people with advanced solid tumors (breast, ovarian, or prostate cancer) that have not responded to prior treatments. The main goals are to check safety, find the right dose, and see if it shrinks tumors. About 156 participants will take the drug by mouth, and researchers will monitor side effects and how the drug moves through the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IMP1734 (a PARP1 inhibitor drug)
- What this could lead to
- If it works, this could point toward a new treatment option for certain advanced cancers like breast, ovarian, or prostate cancer.
- What could go wrong
- This is an early phase 1/2 trial with a small number of participants, so it may not show strong anti-tumor effects. Side effects are possible, and the drug may not work for all tumor types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Advent Health Research Institute
RECRUITINGCelebration, Florida, 34747, United States
-
CHA Bundang Medical Center, CHA University
RECRUITINGSeongnam-si, Gyeonggi-do, 13496, South Korea
-
CLCC François Baclesse
RECRUITINGCaen, 14075, France
-
Cayuga Medical Center
WITHDRAWNIthaca, New York, 14850, United States
-
Chongqing University Cancer Hospital
RECRUITINGChongqing, 400044, China
-
Clínica Universidad de Navarra - Hospital
RECRUITINGPamplona, Navarre, 31008, Spain
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 200120, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, 350000, China
-
Fundacion MD Anderson Cancer Center
RECRUITINGMadrid, 28033, Spain
-
Gachon University - Gil Medical Center
RECRUITINGIncheon, Namdong-gu, 21565, South Korea
-
Gold Coast Private Hospital
NOT_YET_RECRUITINGSouthport, Queensland, 4125, Australia
-
Henry Ford Health
RECRUITINGDetroit, Michigan, 48202, United States
-
Hoag Health Center Irvine
WITHDRAWNIrvine, California, 92618, United States
-
Hospices Civils de Lyon - CHU Lyon Sud
RECRUITINGPierre-Bénite, Rhone, 69310, France
-
Hospital Clinico San Carlos
RECRUITINGMadrid, Madrid, 28040, Spain
-
Hospital Clinico Universitario de Valencia - INCLIVA
RECRUITINGValencia, 46010, Spain
-
Hospital Universitari Parc Taulí
RECRUITINGSabadell, Barcelona, 08208, Spain
-
Hospital del Mar
RECRUITINGBarcelona, 08003, Spain
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
John Theurer Cancer Center
WITHDRAWNHackensack, New Jersey, 07601, United States
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Lifespan Cancer Institute
RECRUITINGProvidence, Rhode Island, 02903, United States
-
Macquarie University
RECRUITINGSydney, Queensland, 2109, Australia
-
Mater Cancer Care Centre, Mater Misericordiae Limited
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Medical University of South Carolina (MUSC) - Hollings CC
RECRUITINGCharleston, South Carolina, 29425, United States
-
Peninsula and south eastern haematology and oncology group
RECRUITINGFrankston, Victoria, 3199, Australia
-
Princess Alexandra Hospital
RECRUITINGWoolloongabba, Queensland, 4102, Australia
-
Princess Margaret Cancer Centre-University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Righospitalet
RECRUITINGCopenhagen, 2100, Denmark
-
START - South Texas Accelerated Research Therapeutics
WITHDRAWNSan Antonio, Texas, 78229, United States
-
START Madrid Fundación Jiménez Díaz
RECRUITINGMadrid, 28040, Spain
-
START Mountain Region
WITHDRAWNWest Valley City, Utah, 84119, United States
-
START-CIOCC HM Sanchinarro Hospital
RECRUITINGMadrid, 28050, Spain
-
Sarah Cannon Research Institue Oncology
RECRUITINGNashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute Health One
RECRUITINGDenver, Colorado, 80218, United States
-
Scientia Clinical Research Ltd
ACTIVE_NOT_RECRUITINGRandwick, New South Wales, 2031, Australia
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
-
Shandong Cancer Hospital
RECRUITINGJinan, Shandong, 250117, China
-
Sharp Memorial Hospital
WITHDRAWNSan Diego, California, 92123, United States
-
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310016, China
-
Smilow Cancer Hospital at Yale New Haven
RECRUITINGNew Haven, Connecticut, 06511, United States
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
Sunnybrook Research Institute
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
Sylvester Comprehensive Cancer Center
RECRUITINGMiami, Florida, 33136, United States
-
The Fourth Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, 050011, China
-
The University of Arizona Cancer Center
RECRUITINGTucson, Arizona, 85719, United States
-
Universidad De Sevilla - Hospital Universitario Virgen Macarena
RECRUITINGSeville, 41009, Spain
-
University California Irvine
WITHDRAWNIrvine, California, 92868, United States
-
University of Arkansas Winthrop P. Rockefeller Cancer Institute
RECRUITINGLittle Rock, Arkansas, 72205, United States
-
University of California San Francisco (UCSF)
WITHDRAWNSan Francisco, California, 94158, United States
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Minnesota-Clinical Research Unit
RECRUITINGMinneapolis, Minnesota, 55455, United States
-
Vall d'Hebron Institute of Oncology
RECRUITINGBarcelona, 08035, Spain
-
Washington University - Siteman Cancer Center
WITHDRAWNSt Louis, Missouri, 63110, United States
-
West Cancer Center & Research Institute
RECRUITINGGermantown, Tennessee, 38138, United States
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, 310022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Chemo combo vs. radioactive drug: which tames aggressive prostate cancer?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Can your own immune cells beat advanced cancer?
- Could ionized gas help fight breast cancer after surgery?